
Become part of our collaborative research network.
- 01 Data access - At the source (HIS)
- 02 Transformer based cNLP enrichment to increase granularity
- 03 Scalable & open-source data standards (FHIR/OMOP CDM)
- 04 Focus on Real World Data Quality (Sentinel/EHDS)
- 05 Future proof: Federated analytics (on similar data models)
- 06 Adding value beyond the data asset
Partners in research & data quality insights & optimization
Where You Can Find Us
Health Tech Forward 2025
On 3 December, Dries will be joining the panel on the "European Health Data Space (EHDS): collaboration and partnerships for successful implementation" at Health Tech Forward in Barcelona.
ESMO AI & Digital Oncology 2025
Meet us at ESMO AI & Digital Oncology 2025, where we will be presenting our poster and be giving a mini oral presentation!
ISPOR Europe 2025
Meet us at ISPOR Europe 2025 this November as we join the global conversation on real-world evidence and health economics. Book a meeting now!
ESMO 2025
We'll be at ESMO 2025 in Berlin! Don't miss out on our poster: "Comprehensive characterization of evolving immune checkpoint inhibitor (ICI) indications and outcomes through automated standardization of multicenter EHR data"
OHDSI Europe 2025
We are thrilled to announce our participation as a Gold Sponsor at the 2025 OHDSI Europe Symposium, taking place from July 5-7. This year, the symposium makes its debut outside its usual Rotterdam setting, in the historic "Old Prison" building of Hasselt University, Belgium. We look forward engaging with fellow health tech innovators, hospitals, and life sciences organizations to shape the future of health data science.
European Lung Cancer Congress 2025
On 26 March, at the European Lung Cancer Congress, Dr. Decoster (UZ Brussels) will be presenting the joint poster "Real-World Biomarker Testing and Treatment Patterns in Belgian Lung Cancer Patients: Insights from the AIBED Study".
Belgian Society of Molecular Oncology 2025 Congress
On January 31st, at the BSMO 2025 Congress, Dr. Nuytemans (AZ Groeninge) unveiled the insights from a Belgian multi-center real-world study in breast cancer patients.
ISPOR Europe 2024
We will be attending ISPOR Europe 2024 in Barcelona. Meet our dream team at booth 1126, and discover real-world data use cases in oncology, cardiology and psychiatry, learn more about our European hospital data network and explore the potential of our state-of-the-art proprietary NLP pipeline.
OHDSI Global 2024
We are attending the 10th annual OHDSI Global symposium.
OHDSI UK 2024
We will be attending the OHDSI UK symposium in London!
ESMO 2024
Join us at the ESMO Congress 2024 from 13-17 September in Barcelona, and discover our 2 posters on (i) the real-world usage and adverse events of immune checkpoint inhibitors, and (ii) cardiovascular toxicities in real-world cancer patients treated with immune checkpoint inhibitors.
OHDSI Europe 2024
Meet us at OHDSI Europe 2024 workshops and symposium! On 3 June, Dr. Annelies Verbiest (UZA) and Clara L. Oeste (LynxCare) will provide insights into our Belgian oncology research network and present the initial results from a study into Lung Cancer patients treated with immune checkpoint inhibitors (ICI).
FAQs
Find answers to your questions about our data solutions and services.
Yes, our OMOP CDM-based approach and federated network architecture enable multi-center, multi-country research collaborations while maintaining data privacy and regulatory compliance.
We have numerous (joint) peer-reviewed publications and conference presentations (e.g. ESMO, ISPOR, ESC Heart Failure) on topics including immune checkpoint inhibitors, cardiovascular toxicities in cancer patients, lung cancer biomarker testing, heart failure management, and the performance of our NLP pipeline, to name a few. Visit our Knowledge Center for the complete library.
The hospital always remains the data controller. LynxCare acts as a data processor, processing data only on behalf of and according to instructions from the hospital. Patient data never leaves the hospital's custody, and hospitals retain full control over how their data is used.
